Molecular Pathology Insights into Hematologic Malignancies: An In-Depth Analysis of Genetic and Chromosomal Abnormalities and Their Clinical Implications - Top-Institutions - MDSpire

Molecular Pathology Insights into Hematologic Malignancies: An In-Depth Analysis of Genetic and Chromosomal Abnormalities and Their Clinical Implications

  • By

  • N. McCaul

  • R. J. Bingham

  • A. D. Blann

  • April 20, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematologic Malignancies
    • Molecular Pathology
    • Cancer Genomics

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology-Oncology
    • Molecular Diagnostics
    • Cancer Genomics

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematologic Malignancies
    • Molecular Pathology
    • Translational Research

  • #4

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Molecular Genetics
    • Cancer Research

  • #5

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Molecular Pathology
    • Hematology-Oncology
    • Genomic Medicine

Original Source(s)

Molecular Pathology Insights into Hematologic Malignancies: An In-Depth Analysis of Genetic and Chromosomal Abnormalities and Their Clinical Implications

  • by N. McCaul, R. J. Bingham, A. D. Blann

  • April 20, 2026

Related Content

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026